US 7179823
5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
granted A61KA61K31/501A61P
Quick answer
US patent 7179823 (5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity) held by Takeda Pharmaceutical Company Limited expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/501, A61P, A61P1/00, A61P1/02